Stay updated on IMP321 for Advanced Solid Tumors Clinical Trial.
Sign up to get notified when there's something new on the IMP321 for Advanced Solid Tumors Clinical Trial. page.

Latest updates to the IMP321 for Advanced Solid Tumors Clinical Trial. page
- Check7 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest has been deleted.SummaryDifference4%
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference4%
- Check28 days agoNo Change Detected
- Check36 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check43 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference6%
- Check50 days agoChange DetectedThe page has removed the mention of 'eftilagimod Alpha' in the title of the section regarding the feasibility and safety of IMP321 for advanced stage solid tumors.SummaryDifference0.3%
- Check72 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.3%
Stay in the know with updates to IMP321 for Advanced Solid Tumors Clinical Trial.
Enter your email address, and we'll notify you when there's something new on the IMP321 for Advanced Solid Tumors Clinical Trial. page.